The biotech is exploring opportunities for a reverse merger or other business combinations. CFO and now interim CEO Anup ...

Research analysts at William Blair issued their Q1 2025 earnings per share estimates for shares of Mersana Therapeutics in a ...

In a report released today, Marc Frahm from TD Cowen maintained a Buy rating on Incyte (INCY – Research Report), with a price target of $88.00. The company’s shares closed tod ...

Students of Chittenango High School will perform Monty Python’s “Spamalot” as their spring 2025 musical. Lovingly ripped off ...

William Blair analyst R. Daniels now forecasts that ... an additional 56,864 shares during the period. Finally, Maple Rock Capital Partners Inc. purchased a new position in Teladoc Health during ...

Corporation announced that one of its stockholders, an affiliate of One Rock Capital Partners, intends to offer for sale in ...

Primo Brands Corporation (NYSE: PRMB) ("Primo Brands" or the "Company") today announced that one of its stockholders (the ...

See salary and bonus figures for more than 900 investment bankers, from analysts to MDs, surveyed by recruiting firm Prospect ...

Rock, the classic military comic that Guadagnino ... rap battle" Toxie turns the Chicago River really green for Macon Blair’s The Toxic Avenger More News ...

Digital physical therapy company Hinge Health filed to go public Monday, signaling a potential revival of the dormant digital ...